A Study to Evaluate Primary Care Treatment for Adolescent Eating Disorders

Overview

About this study

The purpose of this study is to finalize the family-based treatment for primary care (FBT-PC) intervention for use in community-based primary care clinics through an open case series. Also, to establish the feasibility and acceptability of FBT-PC for caregivers, patients, and PCPs in these community-based settings in a pilot randomized controlled trial. Finally, to test preliminary target engagement of FBT-PC in community-based primary care clinics and determine whether it is associated with improved caregiver self-efficacy and, through this mechanism, symptom remission. Remission will be defined as weight restoration to 95% of expected body weight and a score within 1 standard deviation (SD) of community norms on the Eating Disorder Examination-Questionnaire.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Diagnosis of a DSM-5 restrictive eating disorder (anorexia nervosa or other specified feeding or eating disorder characterized by dietary restriction and/or weight loss or failure to make expected weight gains).
Eligible patients will have at least one caregiver who is also willing to participate in the study.
Eligible patients must receive primary care through one of 3 MCHS sites connected to the study: Onalaska/La Crosse, Redwing, and Faribault.

Exclusion Criteria:

Patients will be excluded who have received FBT in the past, and/or who report active suicidality.
Patients who become physically or psychiatrically unstable during the study will be re-evaluated and referred for appropriate treatment.
Patients will be excluded if their enrolled caregiver has active substance dependence, mental health concerns that make it difficult to engage in treatment, or are perpetrators of abuse.

Eligibility last updated 11/10/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Jocelyn Lebow, Ph.D., L.P.	Open for enrollment	Contact information: Aiya Abdelrahman Siddig (507) 422-3895 Siddig.Aya@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Jocelyn Lebow, Ph.D., L.P.

Open for enrollment

Contact information:

Aiya Abdelrahman Siddig

(507) 422-3895

Siddig.Aya@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials